News
Video
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis.
Pharmacy Times® interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62nd American Society of Hematology Annual Meeting & Exposition.
The full conversation can be found in the video above.